Search - tctmd.com

Displaying 661 - 680 of 933

Sort: Relevancy | Date

News Daily News

Traditional Chinese Medicine May Aid in Prevention of Cardiovascular Disease

L.A. McKeown

June 12, 2017

News Daily News

Run to Your Heart’s Content: Marathons Not Linked With Subclinical Atherosclerosis

Michael O'Riordan

June 09, 2017

News Conference News EuroPCR 2017

My Takeaways From EuroPCR 2017: Everything Perfect, Until It’s Not

Shelley Wood

June 02, 2017

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for May 2017

Shelley Wood

June 01, 2017

News Industry News

Medtronic Enrolls First Patient in Study of IN.PACT(TM) AV Access Drug-Coated Balloon in Patients with End-Stage Renal Disease

May 25, 2017

News Conference News EuroPCR 2017

Scaffold Thrombosis ‘Unpredictable’ With Absorb: AIDA Analysis

Michael O'Riordan

May 19, 2017

News Conference News EuroPCR 2017

FFR-SEARCH Explores Potential of Physiologic Assessment After PCI

Caitlin E. Cox

May 18, 2017

No Very Late Scaffold Thrombosis Risk With Absorb BVS in China, Japan

News Conference News EuroPCR 2017

No Very Late Scaffold Thrombosis Risk With Absorb BVS Studies in China, Japan

Michael O'Riordan

May 17, 2017

News Daily News

Abbott Vascular Recalls Three Coronary Catheters Because of Possible Sheath Removal Problems

Todd Neale

May 16, 2017

News Conference News EuroPCR 2017

iFR and FFR Equally Safe for Deferring Revascularization, Pooled Analysis Shows

Caitlin E. Cox

May 16, 2017

News Conference News EuroPCR 2017

Big Questions for Bioresorbable Scaffolds: Experts and Innovators Debate

Michael O'Riordan

May 15, 2017

News Conference News SCAI 2017

Bioresorbable Scaffolds: Where Do We Go From Here?

L.A. McKeown

May 15, 2017

News Conference News EuroPCR 2017

EuroPCR 2017: New Stents, New Questions for PCI Today and Tomorrow as Angioplasty Turns 40

Shelley Wood

May 12, 2017

News Features

Absorb in Europe: When, How, and by Whom the Beleaguered BVS Is Being Used After Restrictions

Michael O'Riordan

May 08, 2017

News Daily News

TCTMD’s Top 10 Most Popular Stories for April 2017

Shelley Wood

April 28, 2017

News Daily News

Absorb Comparable to Xience in Economic Analysis, but BVS Safety Concerns Could Alter Balance

Michael O'Riordan

April 18, 2017

News Daily News

Treating In-Stent CTOs May Be Riskier Than De Novo CTOs Despite Similar Procedural Success

Yael L. Maxwell

April 17, 2017

News Daily News

Yet Another Study Underscores Drawbacks of Risk-Adjusted Mortality as a Measure of PCI Quality

Todd Neale

April 04, 2017

News Daily News

Scaffold Thrombosis Concerns With Absorb BVS Echoed in AIDA Trial

Michael O'Riordan

March 29, 2017

News Conference News ACC 2017

My Takeaways From ACC 2017: Even With a Sea Change, the Tide Takes Its Time

Shelley Wood

March 23, 2017

Advertisement

Traditional Chinese Medicine May Aid in Prevention of Cardiovascular Disease

Run to Your Heart’s Content: Marathons Not Linked With Subclinical Atherosclerosis

My Takeaways From EuroPCR 2017: Everything Perfect, Until It’s Not

TCTMD’s Top 10 Most Popular Stories for May 2017

Medtronic Enrolls First Patient in Study of IN.PACT(TM) AV Access Drug-Coated Balloon in Patients with End-Stage Renal Disease

Scaffold Thrombosis ‘Unpredictable’ With Absorb: AIDA Analysis

FFR-SEARCH Explores Potential of Physiologic Assessment After PCI

No Very Late Scaffold Thrombosis Risk With Absorb BVS Studies in China, Japan

Abbott Vascular Recalls Three Coronary Catheters Because of Possible Sheath Removal Problems

iFR and FFR Equally Safe for Deferring Revascularization, Pooled Analysis Shows

Big Questions for Bioresorbable Scaffolds: Experts and Innovators Debate

Bioresorbable Scaffolds: Where Do We Go From Here?

EuroPCR 2017: New Stents, New Questions for PCI Today and Tomorrow as Angioplasty Turns 40

Absorb in Europe: When, How, and by Whom the Beleaguered BVS Is Being Used After Restrictions

TCTMD’s Top 10 Most Popular Stories for April 2017

Absorb Comparable to Xience in Economic Analysis, but BVS Safety Concerns Could Alter Balance

Treating In-Stent CTOs May Be Riskier Than De Novo CTOs Despite Similar Procedural Success

Yet Another Study Underscores Drawbacks of Risk-Adjusted Mortality as a Measure of PCI Quality

Scaffold Thrombosis Concerns With Absorb BVS Echoed in AIDA Trial

My Takeaways From ACC 2017: Even With a Sea Change, the Tide Takes Its Time

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content